Contact us
    First Immune - GcMAF
    Office Hours: 8:30am - 5:30pm (GMT)
    Clos de Balade 21, 1140 Evere, Brussels, Belgium
    Tel: +44 (0) 7781 411 737
    Fax: +44 (0) 1481 674 900
    Email: [email protected]

Products and research for the human immune system

Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation (Abstract)

Alpha-N-acetyl galactosaminidase (alpha-NaGalase) has been reported to accumulate in serum of cancer patients and be responsible for deglycosylation of Gc protein, which is a precursor of GcMAF-mediated macrophage activation cascade, finally leading to immunosuppression in advanced cancer patients.
We studied the biochemical characterization of alpha-NaGalase from several human tumor cell lines. We also examined its effect on the potency of GcMAF to activate mouse peritoneal macrophage to produce superoxide in GcMAF-mediated macrophage activation cascade. The specific activity of alpha-NaGalases from human colon tumor cell line HCT116, human hepatoma cell line HepG2, and normal human liver cells (Chang liver cell line) were evaluated using two types of substrates; GalNAc-alpha-PNP (exo-type substrate) and Gal-beta-GalNAc-alpha-PNP (endo-type substrate).
Tumor-derived alpha-NaGalase having higher activity than normal alpha-NaGalase, had higher substrate specificity to the exo-type substrate than to the endo-type substrate, and still maintained its activity at pH 7. GcMAF enhance superoxide production in mouse macrophage, and pre-treatment of GcMAF with tumor cell lysate reduce the activity.
We conclude that tumor-derived alpha-NaGalase is different in biochemical characterization compared to normal alpha-NaGalase from normal Chang liver cells. In addition, tumor cell-derived alpha-NaGalase decreases the potency of GcMAF on macrophage activation.

Article Outline

1. Introduction
2. Materials and methods
2.1. Materials
2.2. Cell culture and sample preparation
2.3. Alpha-N-acetyl-galactosaminidase activity assay
2.4. Isolation and culture of mouse peritoneal macrophages
2.5. Superoxide generation assay
2.6. GcMAF preparation
3. Results
3.1. Alpha-NaGalase activities in human tumor cell lines
3.2. GcMAF-mediated macrophage activation cascade and effect of alpha-NaGalase
4. Discussion
Acknowledgements
References

Source: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VNH-44YF922-2&_user=10&_coverDate=05%2F31%2F2002&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=bf5f235de743ce09345a565275d4df12

Author Keywords: Alpha-N-acetylgalactosaminidase; Gal-beta-GalNAc-alpha-PNP; GalNAc-alpha-PNP; GcMAF-mediated macrophage activation cascade; Gc protein-derived macrophage activating factor (GcMAF); Mouse peritoneal macrophage; Superoxide; Tumor cells

 

Erratum to “Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation”: [Comp. Biochem. Physiol. A 132 (2002) 1–8]
Comparative Biochemistry and Physiology – Part A: Molecular & Integrative PhysiologyVolume 134, Issue 2February 2003Page 481,
Saharuddin B. Mohamad, Hideko Nagasawa, Yoshihiro Uto, Hitoshi Hori
 PDF (30 K)

 

© 2013 First Immune - GcMAF All Rights Reserved | Site built by STRATAGEMdesign
go to top